Malignant Head and Neck Mucosal Neoplasm

Malignant Head and Neck Mucosal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

466 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 163
Recruiting: 80
Ph III recruiting: 9
Growth YoY: +33.3%
Industry share: 7%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (63)

clinicaltrialsPublishedShowing 151–200 of 466 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01932697	Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer	completed	Phase 2	81	Mayo ClinicOTHER	1	Feb 10, 2026	clinicaltrials
NCT05551117	A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors(Tamarack)	terminated	Phase 2	192	MacroGenicsINDUSTRY	9	Feb 9, 2026	clinicaltrials